Advertisement
Advertisement

RAPT

RAPT logo

RAPT Therapeutics Inc

0.8319
USD
-0.0092
-1.09%
Dec 18, 15:58 UTC -5
Closed
...

RAPT Therapeutics Inc Profile

About

RAPT Therapeutics Inc. is a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for oncology and inflammatory diseases. The company's drug candidate consists of FLX475 for the treatment of tumors and RPT193, a CCR4 antagonist for allergic inflammatory disease. RAPT Therapeutics Inc. is based in San Francisco, California.

Info & Links

CEO

Brian Wong

Headquarters

561 ECCLES AVENUE
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.rapt.com

Auditor

Ernst & Young LLP

Share holders

33

Employees

131

RAPT Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

29.08M

Enterprise Value

-8.82M

Enterprise Value/EBITDA(ttm)

0.08

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-89.10%

Return on Invested Capital(ttm)

-88.95%

Return on Assets(ttm)

-76.13%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-117.12M

Net Income Available to Common(ttm)

-107.49M

Diluted EPS(ttm)

-2.77

Share Statistics

Beta (5Y Monthly)

0.07

52-Week Change

-94.99%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

34.96M

Dividend Yield

0.00%

Float4

32.65M

% Held by Insiders

6.60%

% Held by Institutions

99.09%

Balance Sheet

Total Cash(mrq)

97.91M

Total Cash Per Share(mrq)

2.80

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.90%

Quick Ratio(mrq)

9.90%

Book Value Per Share(mrq)

2.74

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.87

Free Cash Flow(ytd)

-72.98M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement